SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Pre-Tax Income
SCI Pharmtech Inc
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Pre-Tax Income
NT$584.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
6%
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Pre-Tax Income
NT$1.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
![]() |
Formosa Laboratories Inc
TWSE:4746
|
Pre-Tax Income
NT$410.7m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
19%
|
CAGR 10-Years
3%
|
|
![]() |
ScinoPharm Taiwan Ltd
TWSE:1789
|
Pre-Tax Income
NT$490.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-5%
|
|
![]() |
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Pre-Tax Income
NT$5.4B
|
CAGR 3-Years
40%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Pre-Tax Income
NT$1.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Pre-Tax Income?
Pre-Tax Income
584.2m
TWD
Based on the financial report for Sep 30, 2024, SCI Pharmtech Inc's Pre-Tax Income amounts to 584.2m TWD.
What is SCI Pharmtech Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
6%
Over the last year, the Pre-Tax Income growth was 24%.